4//SEC Filing
Caissa Capital Management ltd. 4
Accession 0001929354-23-000011
CIK 0001534120other
Filed
May 29, 8:00 PM ET
Accepted
May 30, 4:27 PM ET
Size
7.7 KB
Accession
0001929354-23-000011
Insider Transaction Report
Form 4
Caissa Capital Management ltd.
10% Owner
Transactions
- Purchase
Common stock
2023-05-25$2.77/sh+2,000$5,540→ 1,384,700 total(indirect: See Footnote (1)) - Purchase
Common stock
2023-05-30$2.87/sh+671$1,924→ 1,385,371 total(indirect: See Footnote (1))
Holdings
- 182,300
Common stock
Footnotes (3)
- [F1]Shares held by Caissa Capital Management Ltd, a British Virgin Islands company controlled by Mr. Golestaneh.
- [F2]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.85 to $2.87, inclusive.
- [F3]These shares are directly owned by Mr. Golestaneh in his personal capacity.
Documents
Issuer
Avalo Therapeutics, Inc.
CIK 0001534120
Entity typeother
IncorporatedVirgin Islands, British
Related Parties
1- filerCIK 0001929354
Filing Metadata
- Form type
- 4
- Filed
- May 29, 8:00 PM ET
- Accepted
- May 30, 4:27 PM ET
- Size
- 7.7 KB